Selected article for: "case CFR fatality rate and CFR fatality rate"
Author: Mehta, Vikas; Goel, Sanjay; Kabarriti, Rafi; Cole, Daniel; Goldfinger, Mendel; Acuna-Villaorduna, Ana; Pradhan, Kith; Thota, Raja; Reissman, Stan; Sparano, Joseph A.; Gartrell, Benjamin A.; Smith, Richard V.; Ohri, Nitin; Garg, Madhur; Racine, Andrew D.; Kalnicki, Shalom; Perez-Soler, Roman; Halmos, Balazs; Verma, Amit
Title: Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
  • Cord-id: a662zibc
  • Document date: 2020_5_1
    • ID: a662zibc
    Snippet: Patients with cancer are presumed to be at increased risk from COVID-19 infection–related fatality due to underlying malignancy, treatment-related immunosuppression, or increased comorbidities. A total of 218 COVID-19–positive patients from March 18, 2020, to April 8, 2020, with a malignant diagnosis were identified. A total of 61 (28%) patients with cancer died from COVID-19 with a case fatality rate (CFR) of 37% (20/54) for hematologic malignancies and 25% (41/164) for solid malignancies.
    Document: Patients with cancer are presumed to be at increased risk from COVID-19 infection–related fatality due to underlying malignancy, treatment-related immunosuppression, or increased comorbidities. A total of 218 COVID-19–positive patients from March 18, 2020, to April 8, 2020, with a malignant diagnosis were identified. A total of 61 (28%) patients with cancer died from COVID-19 with a case fatality rate (CFR) of 37% (20/54) for hematologic malignancies and 25% (41/164) for solid malignancies. Six of 11 (55%) patients with lung cancer died from COVID-19 disease. Increased mortality was significantly associated with older age, multiple comorbidities, need for ICU support, and elevated levels of D-dimer, lactate dehydrogenase, and lactate in multivariate analysis. Age-adjusted CFRs in patients with cancer compared with noncancer patients at our institution and New York City reported a significant increase in case fatality for patients with cancer. These data suggest the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population. SIGNIFICANCE: COVID-19 in patients with cancer is associated with a significantly increased risk of case fatality, suggesting the need for proactive strategies to reduce likelihood of infection and improve early identification in this vulnerable patient population. This article is highlighted in the In This Issue feature, p. 890

    Search related documents:
    Co phrase search for related documents
    • absolute neutrophil count and academic medical center: 1
    • absolute neutrophil count and active chemotherapy: 1
    • absolute neutrophil count and active disease: 1, 2
    • absolute neutrophil count and active therapy: 1
    • absolute neutrophil count and active treatment: 1, 2
    • absolute neutrophil count and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • absolute neutrophil count and acute septic shock respiratory distress syndrome: 1
    • absolute neutrophil count and logistic model: 1, 2
    • absolute neutrophil count and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • absolute neutrophil count and lung cancer: 1
    • academic center and active cancer treatment: 1
    • academic center and active chemotherapy: 1, 2
    • academic center and active therapy: 1
    • academic center and active treatment: 1, 2, 3, 4, 5
    • academic center and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • academic center and logistic model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • academic center and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • academic center and lung cancer: 1, 2
    • academic medical center and active chemotherapy: 1